<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <title>Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis - VetSRev</title>
  <link rel="stylesheet" href="/vendor/bootstrap-4.3.1.min.css">
  <link rel="stylesheet" href="/vendor/fontawesome-5.8.1.min.css">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,700;1,400&display=swap" rel="stylesheet">

  <link rel="stylesheet" href="/assets/style.css" media="screen" type="text/css">

  <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
  <link rel="manifest" href="/site.webmanifest">
</head>

<body>
  <!-- HEADER -->
  <div class="header">
    <div class="container">
      <img src="/assets/CEVMLogo.png" alt="logo"/>
      <div class="title">
        <h1>VetSRev</h1>
        <p class="hidden-xs">Database of veterinary systematic reviews</p>
      </div>
    </div>
  </div>

  <!-- Navigation -->
  <div class="container">
    <nav class="navbar navbar-expand navbar-light bg-light">
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>

      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav mr-auto">
          <li class="nav-item"><a class="nav-link" href="/">Home</a></li>
          <li class="nav-item"><a class="nav-link" href="/about.html">About the database</a></li>
        </ul>
      </div>
    </nav>
  </div>

  <!-- CONTENT -->
  <div class="container">
  <div class="publication">
  <h1>Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis</h1>
  <h2>Xu, J. and Long, Y. and Ni, L. and Yuan, X. and Yu, N. and Wu, R. and Tao, J. and Zhang, Y.</h2>

  
  <p>BMC Cancer (2019) 19: 589</p>
  

  
  <p>DOI: <a href="https://doi.org/10.1186/s12885-019-5791-1">10.1186/s12885-019-5791-1</a></p>
  

  
  <h2>Abstract</h2>
  <p>BACKGROUND: Numerous studies have explored the anti-tumor effect of berberine (BBR), but little clinical evidence guides the use of BBR in cancer patients. OBJECTIVES: Our aim was to investigate the impact of BBR on various cancers in healthy animals to promote the transformation from bench to bed. SEARCH METHODS: PubMed, Embase, Springer, and Cochrane databases were searched from January 2000 to October 2018 for relevant articles. SELECTION CRITERIA: Only published studies focusing on the relationship between BBR and various cancers in vivo were qualified. Two review authors independently assessed the risk of bias for each study, and any disagreement was resolved by discussion or by involving a third assessor. RESULTS: A total of 26 studies from 2000 to 2018, focusing on various cancer types, including breast cancer, liver cancer, colorectal cancer, nasopharyngeal carcinoma, lung cancer, gastric cancer, neuroepithelial cancer, endometrial carcinoma, esophageal cancer, tongue cancer, cholangiocarcinoma, and sarcoma were included. Overall, BBR reduced tumor volume (SMD =3.72, 95% CI: 2.89, 4.56, Z = 8.73, p \textless 0.00001) and tumor weight (SMD =2.35, 95% CI: 1.51, 3.19, Z = 5.50, p \textless 0.00001) in a linear The dose-response relationship (Pearson r = - 0.6717, p \textless 0.0001 in tumor volume analysis; Pearson r = - 0.7704, p \textless 0.0005 in tumor weight analysis). BBR inhibited angiogenesis in tumor tissues (SMD = 4.29, 95% CI: 2.14, 6.44, Z = 3.92, p \textless 0.00001), but it had no significant effect on the body weight of experimental animals (SMD = 0.11, 95% CI: - 0.70, 0.92, Z = 0.27, p = 0.78). Publication bias was not detected. CONCLUSION: BBR exerted anti-tumor effects in a variety of tumors in vivo, especially breast cancer and lung cancer, and the evidence was still insufficient in colorectal cancer and gastric cancer.</p>
  

  <h2>Citation</h2>
  <p class="citation"><span id="xu_anticancer_2019">Xu, J., Long, Y., Ni, L., Yuan, X., Yu, N., Wu, R., Tao, J., &amp; Zhang, Y. (2019). Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. <i>BMC Cancer</i>, <i>19</i>(1), 589. https://doi.org/10.1186/s12885-019-5791-1 <b>Animals, Horses, Sheep, Dogs, Humans, Mice, Rats, Rabbits, Body Weight, Meta-analysis, Disease Models, Animal, Haplorhini, Cancer, Guinea Pigs, Cricetinae, Dose-Response Relationship, Drug, Tumor Burden, Neoplasms/*drug therapy/metabolism, Berberine, *Phytotherapy, Angiogenesis Inhibitors/administration &amp; dosage/adverse effects/*therapeutic use, Antineoplastic Agents/administration &amp; dosage/adverse effects/*therapeutic use, Berberine/administration &amp; dosage/adverse effects/*therapeutic use, Berberis/chemistry, Experimental animals, Plant Extracts/therapeutic use</b></span> </p>


  <h2>Keywords</h2>
  <ul>
    
    
      <li>Animals</li>
    
      <li>Horses</li>
    
      <li>Sheep</li>
    
      <li>Dogs</li>
    
      <li>Humans</li>
    
      <li>Mice</li>
    
      <li>Rats</li>
    
      <li>Rabbits</li>
    
      <li>Body Weight</li>
    
      <li>Meta-analysis</li>
    
      <li>Disease Models</li>
    
      <li>Animal</li>
    
      <li>Haplorhini</li>
    
      <li>Cancer</li>
    
      <li>Guinea Pigs</li>
    
      <li>Cricetinae</li>
    
      <li>Dose-Response Relationship</li>
    
      <li>Drug</li>
    
      <li>Tumor Burden</li>
    
      <li>Neoplasms/*drug therapy/metabolism</li>
    
      <li>Berberine</li>
    
      <li>*Phytotherapy</li>
    
      <li>Angiogenesis Inhibitors/administration & dosage/adverse effects/*therapeutic use</li>
    
      <li>Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use</li>
    
      <li>Berberine/administration & dosage/adverse effects/*therapeutic use</li>
    
      <li>Berberis/chemistry</li>
    
      <li>Experimental animals</li>
    
      <li>Plant Extracts/therapeutic use</li>
    
  </ul>

</div>

  </div>

  <!-- FOOTER -->
  <div class="container">
    <div class="footer">


      <h3>VetSRev</h3>
      <p class="strap">Database of veterinary systematic reviews</p>

      <p>To cite this resource please use the following:</br>
      Veterinary Systematic Review database (2021) VetSRev database (Version 2.0). Available at: https://vetsrev.nottingham.ac.uk.</p>


      <p class="smallprint"><a href="/cookies.html">Cookies policy</a></p>

    </div>
  </div>

  <!-- Cookie-Alert -->
  <div class="alert alert-dark alert-dismissible cookiealert" role="alert">

    We'd like to set some analytics cookies to help us improve our website.

    <a href="/cookies/">Learn more.</a>
    <button type="button" class="btn btn-outline-secondary btn-sm declinecookies" data-dismiss="alert">Decline</button>
    <button type="button" class="btn btn-primary btn-sm acceptcookies">Accept</button>

    <button type="button" class="close" data-dismiss="alert" aria-label="Close">
      <span aria-hidden="true">&times;</span>
    </button>
  </div>


  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="/vendor/jquery-3.5.1.min.js"></script>
  <script src="/vendor/popper.min.js "></script>
  <script src="/vendor/bootstrap-4.3.1.min.js "></script>

  


  


  <!-- cookies and Google Analytics-->
  <script src="/assets/cookies.js "></script>

</body>
</html>
